Lilly Is Selling Zepbound Vials at 50% Discount to Shots | Bloomberg Businessweek

Watch Carol and Tim LIVE every day on KZbin: bit.ly/3vTiACF (bit.ly/3vTiACF).
Bloomberg News Health Care Reporter Madison Muller discusses Eli Lilly selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome supply shortages of wildly popular shots. Silvio Tavares, CEO of VantageScore, provides the firm's credit data gauge of consumers. Bloomberg Businessweek Senior Editor Bret Begun shares stories from the Businessweek Magazine package on sports gambling. Ian Rogers, Chief Experience Officer at Ledger, talks about providing digital asset security for consumers and enterprises. And we Drive to the Close with Emily Roland, Co-Chief Investment Strategist at John Hancock Investment Management.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener (omnystudio.com...) for privacy information.
Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.
Subscribe to Bloomberg Podcasts: bit.ly/Bloombe...
Listen to more of Bloomberg Businessweek: • Bloomberg Businessweek
#Bloomberg #Podcast #News #Businessweek
Visit us: www.bloomberg....
Follow Bloomberg Podcasts on Twitter: / podcasts
Visit our other KZbin channels:
Bloomberg Television: / @markets
Bloomberg Originals: / bloomberg
Quicktake: / @bloombergquicktake
For coverage on news, markets and more: www.bloomberg.c...

[@ListenAnObserve]

How is this going to affect the stock and it's holders?